Objective: the frequency of bone marrow infiltration by Hodgkin lymphoma is low and varies from 3 to 18%. Hence there exists a dilemma whether bone marrow staging should be done only in the high risk cases. this study aims to study the clinicopathological features and the histomorphology of bone marrow infiltration by Hodgkin lymphoma.
. Studies have shown that the frequency of BM involvement in Hl is low and varies from 4 to 18% (4) (5) (6) (7) . Hence some authors have suggested that BM studies can be done in selected high risk cases alone (5, 8, 9) . However, a controversy exists as few other authors suggest that BM should be done in all the adult cases (1, 10) . This study was done to detect the frequency and morphology of BM involvement in Hl, to study the association of BM involvement with various clinical and hematological parameters and to find whether BM involvement is restricted to certain high risk groups alone. 
MAteRiAlS and MethodS

Cases of
ReSultS
We included a total of 81 cases of Hl having both BM aspirates and biopsies in our study. Fifteen (18.5%) patients belonged to the pediatric age group and 66 (81.5%) patients were adults. Sixty (74.1%) patients were male and 21(25.9%) were female. among the histological subtypes, 54 cases were of the nodular sclerosis subtype, 20 were mixed cellularity Hl, four were lymphocyte rich Hl and three were lymphocyte depleted Hl.
ten of the 81 cases (12.3%) of Hl showed infiltration by Hl in the trephine biopsy sections. However, none of these cases showed features of infiltration in BM aspirate smears.
Seven of the ten cases with BM infiltration showed diffuse involvement and the other three showed focal involvement. One case showed focal BM necrosis while another case showed marrow fibrosis along with tumor cells. Classical or multinucleated Reed-Sternberg and mononuclear Hodgkin cells amidst were seen in a polymorphous inflammatory background of eosinophils, lymphocytes, plasma cells and neutrophils ( Figure 1 ) in eight cases (80%) while mononuclear Hodgkin cells alone were recognized in two cases (20%). CD30 was positive in all the cases (Figure 2 ), but CD15 positivity was seen in eight cases (80%). BM involvement was more common in the lymphocyte depleted (66.7%) and mixed cellularity (20%) subtypes of Hl when compared to the nodular sclerosis (7.4%) and lymphocyte rich (none) subtypes in our study. Vassilakopoulos et al. had also observed that BM involvement is more common in the lymphocyte depleted and mixed cellularity subtypes of Hl (9) . Thus these two subtypes are the high risk subtypes for BM involvement in Hl.
BM involvement was more common in patients with B symptoms and cytopenia when compared to patients without these findings. in our study, among cytopenias, thrombocytopenia and leucopenia were seen in Hl patients only when there was BM involvement. B symptoms and cytopenia were frequently associated with BM involvement in other studies as well (9, 10, 22) .
B symptoms, cytopenias, lymphocyte depleted and mixed cellularity subtypes are therefore risk factors for developing BM involvement in Hl. in particular, leucopenia and thrombocytopenia indicate a high degree of risk. When
Peripheral blood cytopenia was noted in 25 of the total 81 patients. Eight out of the 25 cases with cytopenia had BM involvement (32%). among these eight cases, peripheral blood showed anaemia alone in 4 cases, anaemia with thrombocytopenia in three cases and leucopenia with thrombocytopenia in one case. all the 17 cases of cytopenia in which BM was not involved had only anemia. leucopenia and thrombocytopenia were not seen in these cases. among the 56 patients without cytopenia, only two had BM involvement (3.6%).
Out of the 10 cases with BM involvement, 8 cases were thought to be of a lower clinical stage before BM examination was done (Stage ia-1 case, Stage iB-2 cases, Stage iia-1 case, Stage iiB-2 cases and Stage iiiB-2 cases). Because of BM involvement, these patients were upgraded to Stage iV.
diSCuSSion
BM studies are a part of the staging workup for Hl as BM involvement is considered Stage iV disease (1, 2) . in spite of the advances like positron emission tomography, BM biopsy is still essential to confirm BM involvement in Hl (11) . although BM involvement has been reported to be less common in Hl when compared to non-Hodgkin lymphomas (4), it is still essential to do BM staging in Hl as it has prognostic significance (5). The incidence of BM involvement in Hl in our study is consistent with the literature, which indicates a range between 3-18 % in many studies (4) (5) (6) (7) (8) .
BM infiltration by Hl more often showed a diffuse pattern in our study. However, focal infiltration was noted in three cases. This indicates the importance of adequate sampling while doing a BM staging in cases of Hl. Cases with focal involvement can be missed unless an adequate length of BM is sampled (1) . BM necrosis and fibrosis were seen in one case each. BM necrosis and fibrosis are findings often associated with BM infiltration of Hl and, when present, should raise the suspicion of BM involvement in a given case (1, 7, 12 (10) . all these data suggest that doing BM staging only in high risk patients might not be sufficient.
Considering that Hl is a unique neoplasm that exhibits geographical variations in its histological subtypes, Epstein-Barr virus association and immunophenotype, it may be assumed that BM infiltration in Hl also differs between populations (2, 14, 15) . Hence large scale studies on individual populations is necessary before deciding whether BM staging procedures in Hl can be restricted in that population to only certain high risk patients. until then, it is advisable to perform BM staging in all patients with Hl, at least in adults.
